← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Novalex Therapeutics, Inc.
Elburn, IL
$1,197,004
Total funding
2
Grants
Funding over time
peak $598.5K · FY2014–15$1M$750K$500K$250K$0
'14
'15
Funding mix
By agency
NIH$1,197,004 · 2
By mechanism
R41$1,197,004 · 2
Investigators at Novalex Therapeutics, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Development of broad spectrum Hepatitis C Virus NS3/4A protease inhibitors$300,000
R41 · FY2015 · AI
Development of broad spectrum Hepatitis C Virus NS3/4A protease inhibitors$300,000
R41 · FY2014 · AI
Development of Novel S. aureus Antibiotics with Reduced Resistance Susceptibility$298,502
R41 · FY2015 · AI
Development of Novel S. aureus Antibiotics with Reduced Resistance Susceptibility$298,502
R41 · FY2014 · AI